Bausch & Lomb (BLCO) Non-Current Assets (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly Non-Current Assets came in at $10.9 billion in Q2 2026, little changed YoY from $11.0 billion in Q2 2025, and down 0.61% on a QoQ basis from $11.0 billion in Q1 2026.
Bausch & Lomb (BLCO) Non-Current Assets (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has 6 years of Non-Current Assets data on file, last reported at $10.9 billion in Q2 2026.
- Quarterly Non-Current Assets changed 0.45% year-over-year to $10.9 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $44.0 billion (up 2.03% YoY) and the FY2025 annual result came in at $11.0 billion, up 3.41% from the prior year.
- Non-Current Assets slipped to $10.9 billion in Q2 2026, from $11.0 billion in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $11.0 billion in Q4 2025 to a low of $8.8 billion in Q3 2022.
- A 5-year average of $10.2 billion and a median of $10.6 billion in 2023 frame the typical range for Non-Current Assets.
- The widest YoY moves for Non-Current Assets: up 20.0% in 2023, down 2.21% in 2023.
- Tracing BLCO's Non-Current Assets over 5 years: stood at $9.0 billion in 2022, then increased by 18.8% to $10.7 billion in 2023, then slipped by 0.18% to $10.7 billion in 2024, then increased by 3.41% to $11.0 billion in 2025, then dropped by 0.98% to $10.9 billion in 2026.
- The last three Non-Current Assets figures came in at $10.9 billion (Q2 2026), $11.0 billion (Q1 2026), and $11.0 billion (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 133.50 Bn | 128.29 Bn | 1.96 Bn | 11.33 Bn |
| 2 | Becton Dickinson | 52.18 Bn | 51.32 Bn | 2.32 Bn | 42.59 Bn |
| 3 | Alcon | 35.52 Bn | 34.16 Bn | 1.68 Bn | 24.47 Bn |
| 4 | Resmed | 33.56 Bn | 32.09 Bn | 861.22 Mn | 4.64 Bn |
| 5 | Medline | 28.58 Bn | 25.90 Bn | 2.22 Bn | 27.61 Bn |
| 6 | West Pharmaceutical Services | 24.94 Bn | 24.51 Bn | 329.20 Mn | 2.27 Bn |
| 7 | Solventum | 15.32 Bn | 14.91 Bn | 1.29 Bn | 10.50 Bn |
| 8 | Cooper Companies | 14.82 Bn | 14.68 Bn | 735.40 Mn | 10.18 Bn |
| 9 | Baxter International | 13.60 Bn | 11.45 Bn | 1.03 Bn | 12.80 Bn |
| 10 | Bausch & Lomb | 6.14 Bn | 5.76 Bn | 867.00 Mn | 10.94 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.94 Bn |
| Mar 31, 2026 | 11.00 Bn |
| Dec 31, 2025 | 11.05 Bn |
| Sep 30, 2025 | 10.98 Bn |
| Jun 30, 2025 | 10.99 Bn |
| Mar 31, 2025 | 10.73 Bn |
| Dec 31, 2024 | 10.68 Bn |
| Sep 30, 2024 | 10.69 Bn |
| Jun 30, 2024 | 10.48 Bn |
| Mar 31, 2024 | 10.55 Bn |
| Dec 31, 2023 | 10.70 Bn |
| Sep 30, 2023 | 10.60 Bn |
| Jun 30, 2023 | 9.00 Bn |
| Mar 31, 2023 | 8.99 Bn |
| Dec 31, 2022 | 9.01 Bn |
| Sep 30, 2022 | 8.84 Bn |
| Jun 30, 2022 | 9.00 Bn |
| Mar 31, 2022 | 9.19 Bn |
| Dec 31, 2021 | 9.19 Bn |